| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09fa84c54c24536575f7f12c1f1db43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c06d114257182ee7efd4c696c5fdb836 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-58 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate |
1996-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_574f223477adcc4f1bc63c3c513df9f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c93d7c364ffa895d3ec57ba90d29c35 |
| publicationDate |
1997-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H0920681-A |
| titleOfInvention |
Method for treating acute myocardial infarction with hirudin and acetylsalicylic acid in patients not undergoing thrombolytic treatment |
| abstract |
(57) Abstract: A method for preventing and preventing the progress of a patient with acute myocardial infarction not undergoing thrombolytic treatment is improved. A method of combined administration of hirudin and acetylsalicylic acid (ASA) to an acute myocardial infarction patient who has not undergone thrombolytic treatment, and a combination of acetylsalicylic acid, which is a platelet inactivating agent, and hirudin, which is a direct thrombin inhibitor, are combined. The present invention provides a pharmaceutical composition for treating an acute myocardial infarction patient who has not been subjected to a thrombolytic treatment. [Effects] By the above method, the prevention and / or prevention of myocardial and cardiovascular course of a patient is improved. The combination of acetylsalicylic acid and hirudin in the above pharmaceutical composition exerts a synergistic effect, which results in higher expression of patent coronary blood vessels and thus in reduction of mortality, and is particularly clinical in AMI patients not undergoing thrombolytic treatment. Bring an economic advantage. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008534552-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009543842-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005027896-A1 |
| priorityDate |
1995-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |